Product NDC: | 60505-0399 |
Proprietary Name: | Diclofenac Sodium |
Non Proprietary Name: | Diclofenac Sodium |
Active Ingredient(s): | 16.05 mg/mL & nbsp; Diclofenac Sodium |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-0399 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA202027 |
Marketing Category: | ANDA |
Start Marketing Date: | 20121104 |
Package NDC: | 60505-0399-5 |
Package Description: | 1 BOTTLE in 1 CARTON (60505-0399-5) > 150 mL in 1 BOTTLE |
NDC Code | 60505-0399-5 |
Proprietary Name | Diclofenac Sodium |
Package Description | 1 BOTTLE in 1 CARTON (60505-0399-5) > 150 mL in 1 BOTTLE |
Product NDC | 60505-0399 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Diclofenac Sodium |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20121104 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | DICLOFENAC SODIUM |
Strength Number | 16.05 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Cyclooxygenase Inhibitors [MoA],Decreased Prostaglandin Production [PE],Nonsteroidal Anti-inflammatory Compounds [Chemical/Ingredient],Nonsteroidal Anti-inflammatory Drug [EPC] |